Demegen Patents

U.S. Patents

Non-naturally Occurring Synthetic Lytic Peptides - US 6,559,281 - 5/6/2003

Antifungal and Antibacterial Peptides - US 6,531,573 - 3/11/2003

Methods for Treating Cystic Fibrosis - US 6,528,488 - 3/4/2003

Method for treatment of immunodeficiency virus infection - US 6,514,692 - 2/4/2003

Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides - US 6,191,110 - 2/20/2001

Plants Producing Lytic Peptides - US 6,084,156 - 7/4/2000

Ubiquitin-Lytic Fusion Gene Constructs, Protein Products Deriving Therefrom, and Methods of Making and Using Same - US 6,018,102 - 1/25/2000

Methods of Enhancing Wound Healing by Stimulating Fibroblast and Keratinocyte Growth In Vivo, Utilizing Amphipathic Peptides - US 6,001,805 - 12/14/1999

Ubiquitin-Lytic Peptide Fusion Gene Constructs, Protein Products Deriving Therefrom, and Methods of Making and Using Same - US 5,955,573 - 9/21/1999

Anti-fungal and anti-bacterial histatin-based peptides - US 5,912,230 - 6/15/99

Anti-fungal D-amino acid histatin-based peptides - US 5,885,965 - 3/23/1999

Method of Combating Mammalian neoplasia, and Lytic Peptides Therefor - US 5,773,413 - 6/30/1998

Methods for Treating Fungal Infections Using Histatin-Based Peptides - US 5,696,078 - 12/9/1997

D-amino acid histatin-based peptides as anti-fungal and anti-bacterial agents - US 5,646,119 - 7/8/1997

Anti-fungal and anti-bacterial histatin-based peptides - US 5,631,228 - 5/20/1997

Method of Enhancing Wound Healing by Stimulating Fibroblast and Keratinocyte Growth In Vivo, Utilizing Amphipathic Peptides - US US 5,561,107 - 10/1/1996

Anti-Fungal Histatin-Based Peptides - US 5,486,503 - 1/23/1996

Back to Top Home | Contact Info